Malabre Richard C — SEC Form 4 filings
SEC reporting owner CIK 2007730. 6 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-02 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 108,060 shares, $239,482 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 30,202 shares @ $2.10 ($63,424) in Akebia Therapeutics, Inc., filed 2025-02-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | 6 | — | 5 legs · 108,060 sh · $239,482 | 8 |
Form 4 filings — Malabre Richard C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 36,142 @ $1.39 · Sale (S): 13,382 @ $1.39 | EDGAR |
| 2026-02-03 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 79,000 @ $0 · Grant/award (A): 119,000 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Akebia Therapeutics, Inc. (AKBA) | Option exercise (M): 15,000 @ $1.68 · Sale (S): 15,000 @ $4.01 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 13,334 @ $3.53 | EDGAR |
| 2025-02-04 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 85,000 @ $0 · Sale (S): 30,202 @ $2.10 · Grant/award (A): 128,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 223,950 @ $0 · Grant/award (A): 336,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2007730 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →